Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects

por Harada, Akiko, Ikushima, Ippei, Haranaka, Miwa, Yanagihara, Aki, Nakayama, Daisuke
Publicado 2019

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study

por Haranaka, Miwa, Yono, Makoto, Kishino, Hiroyuki, Igarashi, Rie, Oshima, Nobuyuki, Sawata, Miyuki, Platt, Heather Loryn
Publicado 2023

Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy J...

por Yonemura, Takuma, Yazawa, Rie, Haranaka, Miwa, Kawakami, Kazuki, Takanuma, Masayuki, Kanzo, Takumi, Stefanidis, Dimitris, Arai, Yasumasa
Publicado 2022

Levocetirizine Oral Disintegrating Tablet: A Randomized Open‐Label Crossover Bioequivalence Study in Healthy Japanese Volunteers

por Ino, Hiroko, Shiramoto, Masanari, Eto, Takashi, Haranaka, Miwa, Irie, Shin, Terao, Takumi, Ogura, Hirofumi, Wakamatsu, Akira, Hoyano, Keiko, Nakano, Atsushi
Publicado 2020

A phase I study of high dose camostat mesylate in healthy adults provides a rationale to repurpose the TMPRSS2 inhibitor for the treatment of COVID‐19

por Kitagawa, Junsaku, Arai, Hayato, Iida, Hiroyuki, Mukai, Jiro, Furukawa, Kenji, Ohtsu, Seitaro, Nakade, Susumu, Hikima, Tomohiro, Haranaka, Miwa, Uemura, Naoto
Publicado 2021

A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults

por Haranaka, Miwa, Baber, James, Ogama, Yoichiro, Yamaji, Masako, Aizawa, Masakazu, Kogawara, Osamu, Scully, Ingrid, Lagkadinou, Eleni, Türeci, Ӧzlem, Şahin, Uğur, Dormitzer, Philip R., Gruber, William C., Lockhart, Stephen
Publicado 2021